Which route is used to administer enoxaparin (LMWH)?

Study for the NCLEX Pharmacology Cardiovascular Drugs Test. Explore multiple choice questions with detailed explanations and hints. Prepare confidently for your NCLEX exam!

Multiple Choice

Which route is used to administer enoxaparin (LMWH)?

Explanation:
Subcutaneous administration is used for enoxaparin because it provides predictable absorption and dose‑response, supports convenient delivery (including outpatient use), and minimizes bleeding risks associated with intramuscular injections. Intravenous use would produce rapid, harder-to-titrate anticoagulation and isn’t the standard approach for LMWHs. Intramuscular injections carry a higher risk of hematoma formation in someone who’s anticoagulated. Intradermal administration would not achieve meaningful systemic anticoagulation.

Subcutaneous administration is used for enoxaparin because it provides predictable absorption and dose‑response, supports convenient delivery (including outpatient use), and minimizes bleeding risks associated with intramuscular injections. Intravenous use would produce rapid, harder-to-titrate anticoagulation and isn’t the standard approach for LMWHs. Intramuscular injections carry a higher risk of hematoma formation in someone who’s anticoagulated. Intradermal administration would not achieve meaningful systemic anticoagulation.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy